Methods for treating HCV

The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mensing, Sven, Podsadecki, Thomas J, Wang, Tianli, Dutta, Sandeep, Lin, Chih-Wei, Bernstein, Barry M, Liu, Wei, Menon, Rajeev M, Campbell, Andrew, Awni, Walid M
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Mensing, Sven
Podsadecki, Thomas J
Wang, Tianli
Dutta, Sandeep
Lin, Chih-Wei
Bernstein, Barry M
Liu, Wei
Menon, Rajeev M
Campbell, Andrew
Awni, Walid M
description The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2016291154BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2016291154BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2016291154BB23</originalsourceid><addsrcrecordid>eNrjZJDwTS3JyE8pVkjLL1IoKUpNLMnMS1fwcA7jYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoZmRpaGhqYmTk5GxkQqAwCMcSMR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods for treating HCV</title><source>esp@cenet</source><creator>Mensing, Sven ; Podsadecki, Thomas J ; Wang, Tianli ; Dutta, Sandeep ; Lin, Chih-Wei ; Bernstein, Barry M ; Liu, Wei ; Menon, Rajeev M ; Campbell, Andrew ; Awni, Walid M</creator><creatorcontrib>Mensing, Sven ; Podsadecki, Thomas J ; Wang, Tianli ; Dutta, Sandeep ; Lin, Chih-Wei ; Bernstein, Barry M ; Liu, Wei ; Menon, Rajeev M ; Campbell, Andrew ; Awni, Walid M</creatorcontrib><description>The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211021&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016291154B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211021&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016291154B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Mensing, Sven</creatorcontrib><creatorcontrib>Podsadecki, Thomas J</creatorcontrib><creatorcontrib>Wang, Tianli</creatorcontrib><creatorcontrib>Dutta, Sandeep</creatorcontrib><creatorcontrib>Lin, Chih-Wei</creatorcontrib><creatorcontrib>Bernstein, Barry M</creatorcontrib><creatorcontrib>Liu, Wei</creatorcontrib><creatorcontrib>Menon, Rajeev M</creatorcontrib><creatorcontrib>Campbell, Andrew</creatorcontrib><creatorcontrib>Awni, Walid M</creatorcontrib><title>Methods for treating HCV</title><description>The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDwTS3JyE8pVkjLL1IoKUpNLMnMS1fwcA7jYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoZmRpaGhqYmTk5GxkQqAwCMcSMR</recordid><startdate>20211021</startdate><enddate>20211021</enddate><creator>Mensing, Sven</creator><creator>Podsadecki, Thomas J</creator><creator>Wang, Tianli</creator><creator>Dutta, Sandeep</creator><creator>Lin, Chih-Wei</creator><creator>Bernstein, Barry M</creator><creator>Liu, Wei</creator><creator>Menon, Rajeev M</creator><creator>Campbell, Andrew</creator><creator>Awni, Walid M</creator><scope>EVB</scope></search><sort><creationdate>20211021</creationdate><title>Methods for treating HCV</title><author>Mensing, Sven ; Podsadecki, Thomas J ; Wang, Tianli ; Dutta, Sandeep ; Lin, Chih-Wei ; Bernstein, Barry M ; Liu, Wei ; Menon, Rajeev M ; Campbell, Andrew ; Awni, Walid M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2016291154BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Mensing, Sven</creatorcontrib><creatorcontrib>Podsadecki, Thomas J</creatorcontrib><creatorcontrib>Wang, Tianli</creatorcontrib><creatorcontrib>Dutta, Sandeep</creatorcontrib><creatorcontrib>Lin, Chih-Wei</creatorcontrib><creatorcontrib>Bernstein, Barry M</creatorcontrib><creatorcontrib>Liu, Wei</creatorcontrib><creatorcontrib>Menon, Rajeev M</creatorcontrib><creatorcontrib>Campbell, Andrew</creatorcontrib><creatorcontrib>Awni, Walid M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Mensing, Sven</au><au>Podsadecki, Thomas J</au><au>Wang, Tianli</au><au>Dutta, Sandeep</au><au>Lin, Chih-Wei</au><au>Bernstein, Barry M</au><au>Liu, Wei</au><au>Menon, Rajeev M</au><au>Campbell, Andrew</au><au>Awni, Walid M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods for treating HCV</title><date>2021-10-21</date><risdate>2021</risdate><abstract>The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2016291154BB2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Methods for treating HCV
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A41%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Mensing,%20Sven&rft.date=2021-10-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2016291154BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true